Performance Impact Venture Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Performance impact venture fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Performance Impact Venture Fund Today - Breaking & Trending Today

Deep Longevity Launched a Free Self-help Application, FuturSelf, Powered by Research Conducted with Harvard Medical School, on Optimizing Future Well-being with Artificial Intelligence

HONG KONG, June 21, 2022 /PRNewswire/ Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announceits collaboration with Dr. Nancy Etcoff of Harvard Medical School. Dr. Etcoff is widely recognized in the field of psychology and is a member of the Harvard University Mind/Brain/Behavior Initiative where she teaches a seminar on "The Science of Happiness." She is also a practicing psychologist at the Massachusetts General Hospital Department of Psychiatry where she is the director of the Program in Aesthetics and Well Being. Today, Deep Longevity, in co-authorship with Dr. Etcoff, has published an article in Aging-US describing a machine learning approach to human psychology: "Optimizing future well-being with artificial intelligence: Self-o ....

Hong Kong , Harvard University , United States , Jamie Gibson , Nancy Etcoff , Vadim Gladyshev , Michael Antonov , Alex Zhavoronkov , Longevity Vision Fund , Prnewswire Endurance Rp Limited Longevity , Program In Aesthetics , Communications Consulting , Harvard Medical School , Longevity Inc , Human Longevity Inc , Harvard University Mind Brain Behavior Initiative , Service Laa , Hospital Department Of Psychiatry , Performance Impact Venture Fund , Deep Longevity , Harvard Medical , Behavior Initiative , Massachusetts General Hospital Department , Chief Longevity Officer , Deep Longeivty , Chief Executive Officer ,

Edifice Health Raises $12M in Funding


Edifice Health, a San Mateo, CA-based immunological health and personalized nutrition company, raised $12m in funding.
The round was led by Leaps by Bayer with participation from Paladin Capital Group, Vertical Venture Partners, Ahren Innovation Capital, Ataraxia Capital Partners, Shanda Grab Ventures, Alafi Capital, and Taisho Pharmaceutical. Seed stage investors include Human Longevity and Performance Impact Venture Fund, Longevity Incubator Fund, Summer Venture Capital, Carlyle Global Advisors, M4 Capital GmbH, and Better Food Ventures.
Leaps by Bayer’s Naveen Krishnan, MD, MPhil, and Paladin Group’s Paul Conley, PhD, will join Edifice’s Board of Directors, alongside Santosh Padki, a San Francisco-based consumer products veteran, and David Furman, PhD, Edifice Founder, Leader of the Stanford Project, and Associate Professor of Applied Artificial Intelligence in Systems and Computational Immunology of Aging at the Buck Institute for Research on Aging. ....

Santosh Padki , Naveen Krishnan , Wolfgang Daum , David Furman , Paul Conley , Longevity Incubator Fund , Paladin Group , Edifice Health , Buck Institute For Research On , Paladin Capital Group , Stanford University , Performance Impact Venture Fund , San Mateo , Vertical Venture Partners , Ahren Innovation Capital , Ataraxia Capital Partners , Alafi Capital , Human Longevity , Summer Venture Capital , Carlyle Global Advisors , Better Food , San Francisco Based , Edifice Founder , Stanford Project , Associate Professor , Applied Artificial Intelligence ,

Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging


Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging
News provided by
Share this article
Share this article
SAN MATEO, Calif., April 22, 2021 /PRNewswire/  Edifice Health, a Silicon Valley emerging company in immunological health and personalized nutrition, today announced a $12 Million investment, led by
Leaps by Bayer.
Through its highly-differentiated approach, Edifice aims to harness previously unattainable insights into the root causes of chronic diseases of aging, followed by delivering highly personalized interventions to improve inflammatory and immune health, and extend healthspan.
Globally, about 71% of annual deaths are attributable to non-communicable diseases of aging, which include cancer, cardiovascular diseases, Type II diabetes, neurodegenerative disorders, and depression. According to the U.S. Centers for Disease Control (CDC), 90% of the n ....

Santosh Padki , Wolfgang Daum , David Furman , Eric Verdin , Juergen Eckhardt , Mark Davis , Robert Tibshirani , Bayer Naveen Krishnan , Edifice Health Inc , Buck Institute For Research On , Longevity Incubator Fund , Bayer Ag , Institute For Immunity , Paladin Capital Group , Us Centers For Disease Control , Vp Corporate Development , Edifice Health , Paladin Group Paul Conley , Stanford University , Performance Impact Venture Fund , Silicon Valley , Disease Control , Stanford Project , National Institute , Capital Group , Vertical Venture Partners ,